• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Risperidone Teva
    / Teva Israel LTD, Israel


    Active Ingredient
    Risperidone 25 mg, 37.5 mg, 50 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial -powder and solvent

    1 x 25 mg

    partial basket chart

    Vial -powder and solvent

    1 x 37.5 mg

    partial basket chart

    Vial -powder and solvent

    1 x 50 mg

    partial basket chart

    Dosage

    This medical product is given by intramuscular injection to the buttock or to the arm muscle every two weeks by a healthcare professional. Injections should be
    alternated between the right and left sides of the body. Do not inject intravenously.


    Indications

    * Treatment of schizophrenia and schizoaffective disorders.
    * Maintenance treatment as monotherapy for bipolar I disorder to delay occurrence of mood episodes.
    * Adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.


    Contra-Indications

    * Hypersensitive (allergic) to the active ingredient (risperidone) or to its metabolite (paliperidone) or to any of the excipients.
    * Hypersensitivity reactions, including anaphylactic reaction and angioedema, have been reported in patients treated with risperidone and paliperidone


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    Pharmathen International SA
    CLOSE